Institutional Thesis
Legacy medical technology iterates incrementally on brittle reagent chemistries. BiQadx rejects chemical reliance in favor of deterministic physical control. We engineer closed-loop ecosystems where mechanical architecture dictates biological outcomes, ensuring absolute reproducibility at the decentralized edge.
Our primary objective: deploying a zero-trust diagnostic network. A patient's biological sample is secured in a compostable polysilicate vessel, isolated via 2MHz ultrasonic standing waves, quantified by multi-modal spectrophotometry, and synthesized through sub-18ms local AI inference—delivering clinical multi-omic mapping instantly.
"Clinical friction is fundamentally an engineering failure. We are deploying the architecture to mathematically eliminate it."
— Architect Directive 01, BiQadx Executing BoardSeven Core Principles
Every decision across BiQadx — from materials selection to algorithm design — is governed by these foundational tenets.
Architecture Before Execution
No sprints without blueprints. Systems and physical architecture are designed and locked before lab work or software development begins.
Physical Control
Emphasis on mechanics and microfluidics over chemical reliance. The device controls the chemistry, not the other way around.
Science Over Claims
No clinical performance claims without peer-reviewed validation data. Stage-appropriate evidence is mandatory before any gate promotion.
Radical Transparency
Every design decision, failure, and pivot is documented. Each system is explicitly tagged with its developmental stage — Concept, R&D, Prototype, Pilot, or Market.
Sustainability by Design
Biodegradable labware and reduced-plastic consumables are embedded from Day 1, not retrofitted as compliance afterthoughts.
AI-Augmented Discovery
AI interprets instrument telemetry to build a diagnostic intelligence engine. It remains decision-support; clinicians remain accountable for final diagnoses.
Open R&D Process
The process is documented and accessible to partners, collaborators, and regulators. No black boxes in governance or design.
Stage-Gated Governance
BiQadx operates under an immutable development ledger. Systems are explicitly tagged by their technical maturity. Progression through these gates requires cryptographically signed design reviews aligned strictly with ISO 13485:2016 and IVDR 2017/746 regulatory frameworks.
Design inputs, architecture brief, risk register. ISO 13485 design control initiated.
Parallel hardware, chemistry, and software tracks. Bench data is internal only.
Full-system bench integration, IQ/OQ/PQ drafting, human factors studies.
Controlled external site deployment, operator training, CAPA activation.
Full regulatory compliance — CE mark / 510(k) — and global commercial launch.
Partner With BiQadx
BiQadx provisions closed-beta system evaluations exclusively to Tier-1 clinical research organizations (CROs), supra-national reference laboratories, and accredited academic validation partners.
Initiate Secure Transmission